BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22832865)

  • 1. Treatment of corneal neovascularization by topical application of ascorbic acid in the rabbit model.
    Lee MY; Chung SK
    Cornea; 2012 Oct; 31(10):1165-9. PubMed ID: 22832865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits.
    Koh CH; Lee HS; Chung SK
    Cornea; 2014 May; 33(5):527-32. PubMed ID: 24608256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of topical infliximab on corneal neovascularization in rabbits.
    Kim JW; Chung SK
    Cornea; 2013 Feb; 32(2):185-90. PubMed ID: 23146933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effect of thalidomide analogue on corneal neovascularization in rabbits.
    Lee YK; Chung SK
    Cornea; 2013 Aug; 32(8):1142-8. PubMed ID: 23739149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of curcumin on corneal neovascularization in rabbit eyes.
    Kim JS; Choi JS; Chung SK
    Curr Eye Res; 2010 Apr; 35(4):274-80. PubMed ID: 20373893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of bevacizumab on corneal neovascularization in rabbits.
    Kim WJ; Jeong HO; Chung SK
    Korean J Ophthalmol; 2010 Aug; 24(4):230-6. PubMed ID: 20714387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of subconjunctival suramin on corneal neovascularization in rabbits.
    Lee HS; Chung SK
    Cornea; 2010 Jan; 29(1):86-92. PubMed ID: 19907290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
    Kim TI; Kim SW; Kim S; Kim T; Kim EK
    Cornea; 2008 Apr; 27(3):349-52. PubMed ID: 18362666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory Effect of Topical Aflibercept on Corneal Neovascularization in Rabbits.
    Park YR; Chung SK
    Cornea; 2015 Oct; 34(10):1303-7. PubMed ID: 26114826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.
    Kang S; Chung SK
    Cornea; 2010 Feb; 29(2):192-6. PubMed ID: 20098156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits.
    Park JH; Joo CK; Chung SK
    Cornea; 2015 Apr; 34(4):449-55. PubMed ID: 25651492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.
    Papathanassiou M; Theodossiadis PG; Liarakos VS; Rouvas A; Giamarellos-Bourboulis EJ; Vergados IA
    Am J Ophthalmol; 2008 Mar; 145(3):424-431. PubMed ID: 18207123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model.
    Ko BY; Kim YS; Baek SG; Lee GW; Kim JM; Jean WS; Lee NS; Kang J
    Cornea; 2013 May; 32(5):689-95. PubMed ID: 23377751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of methotrexate on corneal neovascularization in rabbits.
    Byun YS; Chung SK
    Cornea; 2011 Apr; 30(4):442-6. PubMed ID: 21389805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats.
    Hashemian MN; Z-Mehrjardi H; Moghimi S; Tahvildari M; Mojazi-Amiri H
    Ophthalmic Res; 2011; 46(1):50-4. PubMed ID: 21212709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline.
    Aydin E; Kivilcim M; Peyman GA; Esfahani MR; Kazi AA; Sanders DR
    Cornea; 2008 May; 27(4):446-53. PubMed ID: 18434849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Combined Photodynamic Therapy and Topical Bevacizumab Treatment on Corneal Neovascularization in Rabbits.
    Kim RY; Chung SK; Kim MS; Ra H
    Cornea; 2016 Dec; 35(12):1615-1620. PubMed ID: 27684458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of corneal angiogenesis by ascorbic acid in the rat model.
    Peyman GA; Kivilcim M; Morales AM; DellaCroce JT; Conway MD
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1461-7. PubMed ID: 17318569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of corneal neovascularization with a nutrient mixture containing lysine, proline, ascorbic acid, and green tea extract.
    Shakiba Y; Mostafaie A
    Arch Med Res; 2007 Oct; 38(7):789-91. PubMed ID: 17845900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bevacizumab on corneal neovascularization in experimental rabbit model.
    Ahmed A; Berati H; Nalan A; Aylin S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):730-6. PubMed ID: 19788671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.